Delivery Order SPE2DB20D3505-SPE2DB23FT9A2

Award Date 3/30/23
Potential Completion Date 3/31/23
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,948.98 firm fixed-price delivery order is for the supply of 4,566,953,974 units of dextroamphetamine-amphetamine 5 mg tablets. The award has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,298.51, is a Firm Fixed Price delivery order for the provision of 4558514394 - Dextroamphetamine-Amphetamine 10 mg tablets in 100-count bottles. The contract has an ultimate completion date of September 16, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dextroamphetamine-Amphetamine 5 mg tablets. The $1,316.40 firm-fixed-price contract has a completion date of November 20, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 19, 2024. The $2,841.94 firm fixed-price delivery order contract is for the supply of 4,566,769,831 tablets of the drug dextroamphetamine-amphetamine 5 mg. The contract has an ultimate completion date of December 20, 2024 and is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $1,273.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in 100s. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award, valued at $1,926.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,285,738 units of dextroamphetamine-amphetamine 15 mg tablets, with a completion date of October 31, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award, valued at $2,411.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566370487 - Dextroamp-Amphetamin 30 MG Tablets in 100-count packages, with an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,558,601,061 units of Dextroamphetamine-Amphetamine 10 mg tablets in 100-count bottles. The award, valued at $1,184.59, is a firm fixed-price delivery order contract with a completion date of September 26, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for dextroamphetamine-amphetamine 10 mg tablets. The contract has a ceiling value of $1,050.86 and runs through January 16, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $2,799.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply dextroamphetamine-amphetamine 30 mg tablets. The contract has a firm fixed price with an ultimate completion date of May 6, 2024. Amerisourcebergen, through its Corporate Office Division, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB23FT9A2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dextroamphetamine-Amphetamine 5 mg tablets. The contract has a ceiling value of $1,615.28 and a performance period through March 31, 2023.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award was not designated with any set-aside requirements, indicating open competition.

Generated 2/27/25, 11:45 AM